Latest real-world evidence with long-durability therapies for neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME).
Credit available for this activity expires: 10/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997563?ecd=bdc_podcast_libsyn_mscpedu)
